| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
16,079 |
15,667 |
$2.39M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,777 |
4,638 |
$759K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,859 |
5,716 |
$549K |
| G0378 |
Hospital observation service, per hour |
2,042 |
892 |
$391K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,324 |
1,298 |
$371K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
8,306 |
8,029 |
$154K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,006 |
981 |
$123K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
259 |
253 |
$86K |
| 80053 |
Comprehensive metabolic panel |
9,640 |
9,153 |
$73K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
18,951 |
17,294 |
$73K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
9,214 |
8,812 |
$63K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,640 |
3,341 |
$46K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
308 |
302 |
$42K |
| 84484 |
|
5,327 |
4,849 |
$37K |
| 70450 |
Computed tomography, head or brain; without contrast material |
840 |
809 |
$34K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
6,036 |
5,341 |
$33K |
| 71046 |
Radiologic examination, chest; 2 views |
2,891 |
2,821 |
$30K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
542 |
538 |
$30K |
| 64415 |
|
105 |
104 |
$26K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
505 |
483 |
$26K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,161 |
2,067 |
$25K |
| 84703 |
|
3,408 |
3,301 |
$23K |
| J3490 |
Unclassified drugs |
6,603 |
4,407 |
$21K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
333 |
327 |
$19K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
161 |
154 |
$19K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
294 |
290 |
$16K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
418 |
369 |
$15K |
| 93971 |
|
283 |
276 |
$14K |
| 83690 |
|
4,110 |
3,973 |
$13K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
102 |
99 |
$13K |
| 64721 |
|
54 |
52 |
$12K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
203 |
202 |
$11K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
241 |
233 |
$10K |
| T1015 |
Clinic visit/encounter, all-inclusive |
472 |
403 |
$10K |
| 80050 |
General health panel |
247 |
240 |
$10K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
344 |
238 |
$9K |
| 71045 |
Radiologic examination, chest; single view |
1,938 |
1,848 |
$9K |
| 82805 |
|
422 |
391 |
$9K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
245 |
230 |
$8K |
| 81001 |
|
4,002 |
3,891 |
$8K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
180 |
180 |
$7K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
20 |
20 |
$7K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
16 |
14 |
$6K |
| 83880 |
|
307 |
296 |
$6K |
| 83735 |
|
1,354 |
1,129 |
$6K |
| 84443 |
Thyroid stimulating hormone (TSH) |
322 |
314 |
$5K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
4,586 |
4,202 |
$5K |
| 85610 |
|
2,227 |
1,915 |
$5K |
| 85730 |
|
1,179 |
1,135 |
$5K |
| 93017 |
|
213 |
205 |
$5K |
| 83605 |
|
885 |
812 |
$4K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
156 |
153 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
580 |
457 |
$4K |
| 62323 |
|
16 |
16 |
$4K |
| 80061 |
Lipid panel |
335 |
327 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
782 |
748 |
$4K |
| 80076 |
|
665 |
612 |
$3K |
| 85379 |
|
448 |
437 |
$3K |
| 88342 |
|
169 |
162 |
$3K |
| 87040 |
|
324 |
213 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
210 |
204 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
210 |
204 |
$3K |
| 70496 |
|
26 |
26 |
$3K |
| J1815 |
Injection, insulin, per 5 units |
393 |
230 |
$3K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
18 |
17 |
$3K |
| 73610 |
|
199 |
193 |
$2K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
238 |
175 |
$2K |
| 93970 |
|
28 |
28 |
$2K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
86 |
85 |
$2K |
| 84100 |
|
524 |
437 |
$2K |
| 72100 |
|
124 |
121 |
$2K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
4,648 |
2,450 |
$2K |
| 73630 |
|
273 |
264 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
336 |
332 |
$2K |
| 81003 |
|
791 |
779 |
$2K |
| 73030 |
|
137 |
132 |
$1K |
| 73130 |
|
173 |
166 |
$1K |
| 85027 |
|
426 |
352 |
$1K |
| 82607 |
|
164 |
157 |
$1K |
| 82962 |
|
1,425 |
1,005 |
$1K |
| 84702 |
|
94 |
83 |
$1K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
4,668 |
3,600 |
$1K |
| 70498 |
|
14 |
14 |
$1K |
| 76937 |
|
231 |
212 |
$1K |
| 86850 |
|
230 |
218 |
$984.94 |
| 71250 |
|
24 |
24 |
$891.31 |
| 90715 |
|
198 |
185 |
$798.53 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
4,793 |
3,837 |
$794.84 |
| 97162 |
|
60 |
60 |
$785.78 |
| 87077 |
|
170 |
165 |
$782.63 |
| 82728 |
|
84 |
81 |
$769.92 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
19 |
14 |
$752.80 |
| 84439 |
|
116 |
110 |
$715.87 |
| 87480 |
|
55 |
54 |
$706.57 |
| 87660 |
|
55 |
54 |
$679.38 |
| 86140 |
|
319 |
284 |
$667.59 |
| 85651 |
|
310 |
276 |
$634.37 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
4,794 |
3,460 |
$585.37 |
| 82565 |
|
158 |
153 |
$556.82 |
| 94726 |
|
27 |
27 |
$553.31 |
| 82746 |
|
82 |
79 |
$552.00 |
| 83540 |
|
98 |
91 |
$549.59 |
| 73562 |
|
62 |
60 |
$527.09 |
| 87186 |
|
119 |
115 |
$524.40 |
| 86901 |
|
238 |
225 |
$514.77 |
| 86900 |
|
238 |
225 |
$508.17 |
| J8501 |
Aprepitant, oral, 5 mg |
114 |
113 |
$499.07 |
| 73560 |
|
60 |
57 |
$498.56 |
| 76942 |
|
253 |
245 |
$479.05 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,561 |
4,690 |
$427.62 |
| 70486 |
|
12 |
12 |
$426.25 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
8,596 |
6,921 |
$405.53 |
| 77336 |
|
20 |
12 |
$402.52 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
44 |
27 |
$361.79 |
| Q9950 |
Injection, sulfur hexafluoride lipid microspheres, per ml |
14 |
12 |
$335.70 |
| 94729 |
|
15 |
15 |
$333.84 |
| 83550 |
|
90 |
86 |
$308.55 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,661 |
3,051 |
$254.80 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
576 |
366 |
$248.49 |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,087 |
512 |
$243.97 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,048 |
778 |
$238.91 |
| 82550 |
|
49 |
46 |
$226.94 |
| 97166 |
|
13 |
12 |
$203.70 |
| 88341 |
|
27 |
24 |
$179.89 |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,585 |
1,780 |
$179.89 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
436 |
354 |
$174.85 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
204 |
173 |
$143.53 |
| 84134 |
|
12 |
12 |
$120.85 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
436 |
366 |
$113.02 |
| 73590 |
|
13 |
13 |
$108.08 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,332 |
1,163 |
$102.87 |
| 94060 |
|
14 |
14 |
$101.23 |
| J2704 |
Injection, propofol, 10 mg |
2,840 |
1,956 |
$95.48 |
| 87070 |
|
27 |
25 |
$91.08 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
3,995 |
3,537 |
$87.16 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
27 |
25 |
$76.23 |
| 97161 |
|
26 |
25 |
$69.97 |
| 80329 |
|
13 |
12 |
$65.31 |
| 80051 |
|
12 |
12 |
$53.90 |
| J2060 |
Injection, lorazepam, 2 mg |
273 |
213 |
$51.81 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
12 |
12 |
$47.43 |
| 84520 |
|
13 |
13 |
$47.30 |
| 96376 |
|
227 |
132 |
$38.69 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
228 |
198 |
$38.39 |
| 73110 |
|
12 |
12 |
$37.95 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
232 |
172 |
$23.11 |
| 87081 |
|
12 |
12 |
$22.62 |
| J7999 |
Compounded drug, not otherwise classified |
1,384 |
866 |
$20.92 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
70 |
58 |
$18.84 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
734 |
605 |
$16.89 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
134 |
129 |
$15.00 |
| 88304 |
|
49 |
49 |
$14.30 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
35 |
12 |
$13.44 |
| 36415 |
Collection of venous blood by venipuncture |
431 |
368 |
$8.28 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
594 |
413 |
$7.16 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
368 |
318 |
$5.34 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,249 |
1,154 |
$4.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
36 |
28 |
$3.71 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
102 |
87 |
$1.53 |
| Q0243 |
Injection, casirivimab and imdevimab, 2400 mg |
19 |
19 |
$0.04 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
164 |
161 |
$0.00 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
52 |
41 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
275 |
264 |
$0.00 |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
60 |
54 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
102 |
61 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
130 |
97 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
28 |
25 |
$0.00 |
| S0028 |
Injection, famotidine, 20 mg |
100 |
59 |
$0.00 |
| J3535 |
Drug administered through a metered dose inhaler |
13 |
13 |
$0.00 |
| C1889 |
Implantable/insertable device, not otherwise classified |
66 |
64 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
28 |
28 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
75 |
68 |
$0.00 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
53 |
12 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
75 |
54 |
$0.00 |
| C1769 |
Guide wire |
12 |
12 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
13 |
12 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
56 |
28 |
$0.00 |